Camazepam
| Camazepam | |
|---|---|
| Camazepam.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | Hepatic |
| Elimination half-life | |
| Excretion | Renal |
| Legal status | |
| CAS Number | |
| PubChem | 3047760 |
| DrugBank | DB01589 |
| ChemSpider | 2310107 |
| KEGG | D01268 |
Camazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and muscle relaxant properties. It is commonly marketed under the trade names Albego, Limpidon, and Paxor.
Pharmacology[edit]
Camazepam is a prodrug for temazepam, meaning it is metabolized in the body to produce the active compound temazepam. It acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA A receptor, which results in its sedative and anxiolytic effects.
Medical Uses[edit]
Camazepam is primarily used for the treatment of anxiety and related disorders. It may also be prescribed for its sedative properties to help with insomnia and for its muscle relaxant properties in the treatment of muscle spasms.
Side Effects[edit]
Common side effects of camazepam include drowsiness, dizziness, and fatigue. Less common side effects can include confusion, depression, and gastrointestinal disturbances. As with other benzodiazepines, there is a risk of dependence and withdrawal symptoms with prolonged use.
Legal Status[edit]
In the United States, camazepam is classified as a Schedule IV controlled substance under the Controlled Substances Act, indicating it has a lower potential for abuse relative to substances in Schedule III but can still lead to physical or psychological dependence.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
